Cero Therapeutics Holdings CERO
OTC CERO
$0.00 0.00 (-19.61%)
As of: Oct 23, 2026 · 12:24 PM EDT

Cero Therapeutics Holdings (CERO) Selling, General & Administrative (2022 - 2026)

Updated

Cero Therapeutics Holdings (CERO) reported Selling, General & Administrative of $2.11 million for Q2 2026, up 7.1% from $1.97 million a year earlier but down 15.8% from the prior quarter.

Analysis

Cero Therapeutics Holdings (CERO) Selling, General & Administrative (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Cero Therapeutics Holdings' Selling, General & Administrative came in at $8.69 million, up 11.2% year-over-year; for FY2025, it was $8.08 million, down 10.1% from FY2024.

  • Selling, General & Administrative has a four-year compound annual growth rate of 138.0% (FY2021 to FY2025).
  • By year, Selling, General & Administrative came in at $8.99 million in FY2024 (+276.5%), $2.39 million in FY2023 (-16.0%), $2.84 million in FY2022 and $251,706 in FY2021.
  • Five-year quarterly Selling, General & Administrative spans a low of $103,065 in Q4 2023 and a high of $2.75 million in Q1 2024.
  • Year over year, Selling, General & Administrative has now increased in each of the last three quarters, with growth averaging 136.8% over the last seven quarters.
  • The high point for year-over-year Selling, General & Administrative in five years was Q3 2024 (growth of 918.6%); the low point was Q4 2023 (a decline of 92.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.51 million (Q1 2026), $2.09 million (Q4 2025) and $1.98 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 6.29 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 3.63 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 5.65 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 1.92 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 3.41 Bn
10 Cero Therapeutics Holdings 210,875.10 -5.27 Mn - 2.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.11 Mn
Mar 31, 2026 2.51 Mn
Dec 31, 2025 2.09 Mn
Sep 30, 2025 1.98 Mn
Jun 30, 2025 1.97 Mn
Mar 31, 2025 2.04 Mn
Dec 31, 2024 1.17 Mn
Sep 30, 2024 2.63 Mn
Jun 30, 2024 2.43 Mn
Mar 31, 2024 2.75 Mn
Dec 31, 2023 103,065.00
Sep 30, 2023 258,013.00
Jun 30, 2023 1.22 Mn
Mar 31, 2023 638,350.00
Dec 31, 2022 1.37 Mn
Sep 30, 2022 786,685.00
Jun 30, 2022 326,580.00
Mar 31, 2022 354,777.00
API Access

Cero Therapeutics Holdings Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CERO&period=max&api_key=YOUR_API_KEY